Barbieri C - Search Results

1

Three-dimensional prostate CT segmentation through fine-tuning of a pre-trained neural network using no reference labeling.

Caughlin K, Shahedi M, Shoag JE, Barbieri C, Margolis D, Fei B. Caughlin K, et al. Among authors: barbieri c. Proc SPIE Int Soc Opt Eng. 2021 Feb;11598:115980L. doi: 10.1117/12.2581963. Epub 2021 Feb 15. Proc SPIE Int Soc Opt Eng. 2021. PMID: 35755405 Free PMC article.

2

Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial.

Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D. Shoag J, et al. JAMA Oncol. 2015 Oct;1(7):984-6. doi: 10.1001/jamaoncol.2015.2993. JAMA Oncol. 2015. PMID: 26291583 Clinical Trial. No abstract available.

3

Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.

Shoag J, Halpern JA, Lee DJ, Mittal S, Ballman KV, Barbieri CE, Hu JC. Shoag J, et al. Among authors: barbieri ce. J Urol. 2016 Oct;196(4):1047-52. doi: 10.1016/j.juro.2016.03.171. Epub 2016 Apr 6. J Urol. 2016. PMID: 27060052

4

Clinical variability and molecular heterogeneity in prostate cancer.

Shoag J, Barbieri CE. Shoag J, et al. Asian J Androl. 2016 Jul-Aug;18(4):543-8. doi: 10.4103/1008-682X.178852. Asian J Androl. 2016. PMID: 27080479 Free PMC article. Review.

5

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

Shoag J, Mittal S, Halpern JA, Scherr D, Hu JC, Barbieri CE. Shoag J, et al. Among authors: barbieri ce. Eur Urol. 2016 Jul;70(1):2-5. doi: 10.1016/j.eururo.2016.01.009. Epub 2016 May 7. Eur Urol. 2016. PMID: 27166670 Free PMC article. Clinical Trial.

6

Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.

Stone BV, Shoag J, Halpern JA, Mittal S, Lewicki P, Golombos DM, Bedretdinova D, Chughtai B, Barbieri CE, Lee RK. Stone BV, et al. BJU Int. 2017 Feb;119(2):298-304. doi: 10.1111/bju.13613. Epub 2016 Aug 23. BJU Int. 2017. PMID: 27480499 Clinical Trial.

7

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.

Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS. Lewicki P, et al. Among authors: barbieri ce. J Urol. 2017 Apr;197(4):1014-1019. doi: 10.1016/j.juro.2016.11.002. Epub 2016 Nov 8. J Urol. 2017. PMID: 27836710

8

Vasectomy and Risk of Prostate Cancer in a Screening Trial.

Shoag J, Savenkov O, Christos PJ, Mittal S, Halpern JA, Askin G, Shoag D, Golan R, Lee DJ, O'Malley P, Najari B, Eisner B, Hu JC, Scherr D, Schlegel P, Barbieri CE. Shoag J, et al. Among authors: barbieri ce. Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1653-1659. doi: 10.1158/1055-9965.EPI-16-0776. Epub 2017 Aug 22. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28830873

9

SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.

Shoag J, Liu D, Blattner M, Sboner A, Park K, Deonarine L, Robinson BD, Mosquera JM, Chen Y, Rubin MA, Barbieri CE. Shoag J, et al. J Clin Invest. 2018 Jan 2;128(1):381-386. doi: 10.1172/JCI96551. Epub 2017 Dec 4. J Clin Invest. 2018. PMID: 29202479 Free PMC article.

10

Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging Visibility.

Shoag JE, Tosoian JJ, Salami SS, Barbieri CE. Shoag JE, et al. Eur Urol. 2019 Jul;76(1):24-26. doi: 10.1016/j.eururo.2019.01.027. Epub 2019 Feb 1. Eur Urol. 2019. PMID: 30712974 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

600 results

Search Page